Summary
Since in a pilot study i.v. IgG was shown to induce a rapid rise of thrombocytes in children with ITP two prospective multicenter ITP studies were started: one comparing i.v. IgG with oral corticosteroids in previously untreated acute ITP, the other investigating the response to i.v. IgG in pretreated acute or chronic ITP in childhood. In this report preliminary results of both studies are summarized. i.v. IgG treatment of acute and chronic ITP is at least as effective as corticosteroid therapy but is not associated with significant side effects. At least some patients with chronic ITP may benefit from i.v. IgG. Longer observation periods are required for further analysis.
Similar content being viewed by others
References
Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1228–1231
Imbach P, Barandun S, Hirt A, Wagner HP (1984) Intravenous immunoglobulin for idiopathic thrombocytopenic Purpura (ITP) in childhood. Am J Pediatr Hematol Oncol (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Imbach, P., Gaedicke, G. & Joller, P. Interim evaluation of two cooperative studies assessing the effects of intravenous immunoglobulin (i.v. IgG) on childhood idiopathic thrombocytopenic purpura (ITP). Blut 48, 357–361 (1984). https://doi.org/10.1007/BF00319963
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00319963